The company reported a third-quarter adjusted loss of -$0.20 per share, falling well short of analysts’ expectations for a $0.22 profit. Revenue came in at $1.62 billion, slightly below the consensus ...

Unum’s core operations remained strong with a 21.4% adjusted operating return on equity. However, the company completed its annual GAAP reserve assumption updates during the quarter, resulting in an ...

(Reuters) -Oil and gas firm Coterra Energy missed Wall Street estimates for third-quarter profit on Monday, as lower oil prices offset a jump in production, but raised its annual production forecast.

Investing.com -- Upwork Inc. (NASDAQ:UPWK) saw its shares surge 14.7% in after-hours trading Monday after the human and AI-powered work marketplace reported third-quarter earnings that significantly ...

Lionsgate Studios (NYSE:LGF.A) stock surged 5.2% in after-hours trading Monday following disclosure that billionaire investor Steve Cohen’s Point72 Asset Management has significantly increased its ...

Bloomberg, in fact, reports that the S&P 500 has spent more than 125 trading sessions above its 50-day moving average, logging the longest such stretch since 2011. Granted, this market continues to be ...

The tire manufacturer posted adjusted earnings of $0.28 per share for the third quarter, surpassing the analyst estimate of ...

The stronger-than-expected revenue was driven by continued expansion across its personalized care offerings, with subscribers climbing 21% year-over-year to about 2.5M. Online revenue jumped 50% from ...

Investing.com -- The Clorox Company (NYSE:CLX) shares rose 3.1% in after-hours trading Monday after the consumer products giant reported better-than-expected fiscal first-quarter results, despite ...

Investing.com -- Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) shares tumbled 9.2% in after-hours trading Monday after the commercial-stage biopharmaceutical company reported third-quarter revenue that ...

Investing.com -- Sarepta Therapeutics (NASDAQ:SRPT) stock fell 22% after the company announced that its ESSENCE study for ultra-rare disease therapies AMONDYS 45 and VYONDYS 53 failed to achieve ...

Investing.com -- Navitas Semiconductor (NASDAQ:NVTS) shares tumbled 8.2% in after-hours trading Monday after the next-generation power semiconductor company reported third-quarter results that missed ...